{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:29:33Z","timestamp":1794684573663,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.eclinm.2026.104251","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:37:21Z","timestamp":1791841041000},"page":"104251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Weight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-6481","authenticated-orcid":false,"given":"Massimo","family":"Nardone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-9253","authenticated-orcid":false,"given":"Luxcia","family":"Kugathasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Daunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6101-2193","authenticated-orcid":false,"given":"Ethan J.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yuan","family":"River Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin V.","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9943-2692","authenticated-orcid":false,"given":"Ani","family":"Orchanian-Cheff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z.I.","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodele","family":"Odutayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-555X","authenticated-orcid":false,"given":"Marcel H.A.","family":"Muskiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2026.104251_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/HYPERTENSIONAHA.124.24123","article-title":"Trends in obesity prevalence among adults with hypertension in the United States, 2001 to 2023","volume":"82","author":"Tu","year":"2025","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.eclinm.2026.104251_bib2","doi-asserted-by":"crossref","first-page":"E549","DOI":"10.1503\/cmaj.241770","article-title":"Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care","volume":"197","author":"Goupil","year":"2025","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104251_bib3","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/HYP.0000000000000202","article-title":"Weight-loss strategies for prevention and treatment of hypertension: a scientific statement from the American Heart Association","volume":"78","author":"Hall","year":"2021","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104251_bib4","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1161\/CIR.0000000000001356","volume":"152","author":"Writing Committee Members\u2217","year":"2025","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104251_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104251_bib6","article-title":"Long-term effects of weight-reducing diets in people with hypertension","volume":"3","author":"Semlitsch","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104251_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archinte.168.6.571","article-title":"Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis","volume":"168","author":"Horvath","year":"2008","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104251_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s40265-018-0946-y","article-title":"Centrally acting drugs for obesity: past, present, and future","volume":"78","author":"Coulter","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.eclinm.2026.104251_bib9","series-title":"Existing and emerging molecular targets for the pharmacotherapy of obesity","author":"Glykofrydi","year":"2015"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104251_bib10","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/dom.15529","article-title":"Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: a meta-analysis and meta-regression","volume":"26","author":"Rivera","year":"2024","journal-title":"Diabetes Obes Metabol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104251_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ajh\/hpaf205","article-title":"GLP-1 receptor agonists and blood pressure: a state-of-the-art review of mechanisms, evidence, and clinical implications","volume":"39","author":"Moiz","year":"2026","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104251_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2213-8587(25)00197-4","article-title":"Beyond a singular focus on GLP-1: why we need a new nomenclature now","volume":"13","author":"Muskiet","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104251_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.eclinm.2026.104251_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102789","article-title":"GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review","volume":"75","author":"Jarade","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.104251_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.eclinm.2026.104251_bib16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.104251_bib17","series-title":"Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration","article-title":"Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity-maximizing version","author":"Lefebvre","year":"2008"},{"key":"10.1016\/j.eclinm.2026.104251_bib18","series-title":"Embase RCT filter","author":"Glanville","year":"2023"},{"key":"10.1016\/j.eclinm.2026.104251_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.104251_bib20","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2008"},{"issue":"19","key":"10.1016\/j.eclinm.2026.104251_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2024-324170","article-title":"Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial","volume":"110","author":"Krumholz","year":"2024","journal-title":"Heart"},{"issue":"705","key":"10.1016\/j.eclinm.2026.104251_bib22","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.3399\/bjgp20X714113","article-title":"Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes","volume":"71","author":"Morris","year":"2021","journal-title":"Br J Gen Pract"},{"issue":"38","key":"10.1016\/j.eclinm.2026.104251_bib23","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"10506","key":"10.1016\/j.eclinm.2026.104251_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(25)00991-2","article-title":"Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials","volume":"406","author":"Wang","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104251_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/HJH.0000000000003903","article-title":"Effects of glucagon-like peptide-1 receptor agonists on blood pressure in overweight or obese patients: a meta-analysis of randomized controlled trials","volume":"43","author":"Wong","year":"2025","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104251_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/jch.14661","article-title":"Effect of weight loss on blood pressure changes in overweight patients: a systematic review and meta-analysis","volume":"25","author":"Yang","year":"2023","journal-title":"J Clin Hypertens"},{"issue":"10157","key":"10.1016\/j.eclinm.2026.104251_bib27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"10522","key":"10.1016\/j.eclinm.2026.104251_bib28","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/S0140-6736(25)01776-3","article-title":"Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?","volume":"406","author":"Muskiet","year":"2025","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104251_bib29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104251_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/oby.24202","article-title":"Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials","volume":"33","author":"Tchang","year":"2025","journal-title":"Obesity"},{"issue":"38","key":"10.1016\/j.eclinm.2026.104251_bib31","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1093\/eurheartj\/ehae564","article-title":"Semaglutide and blood pressure: an individual patient data meta-analysis","volume":"45","author":"Kennedy","year":"2024","journal-title":"Eur Heart J"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026005043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026005043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:55:41Z","timestamp":1794682541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026005043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S2589537026005043"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104251","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104251"}}